Ranolazine partially blunts ado trastuzumab emtansine related cardiotoxicity

Back

HFA Premium Access

Ranolazine partially blunts ado trastuzumab emtansine related cardiotoxicity

Session: Poster session 3 - Basic science - Translational biomarkers and cardio-renal syndrome

Topic: Cancer/Cardiotoxicity

Speaker: Doctor N. Maurea (Naples, IT)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

About the speaker

Doctor Nicola Maurea

National Cancer Institute G.Pascale Foundation IRCCS, Naples (Italy)

2 presentations

2 followers

5 more presentations in this session

Customized laboratory TLR4 and TLR2 detection method from peripheral human blood for early detection of doxorubicin induced cardiotoxicity

Speaker: Assistant Professor M. Trofenciuc (Arad, RO)

Access

Abstract

Cardiotoxic effects of the novel anti-ErbB2 agent Ado trastuzumab emtansine

Speaker: Doctor N. Maurea (Naples, IT)

Access

Abstract

Slides

Cardiorotective effect of non-peptidic pkr1 agonist against anthracycline-cardiotoxicity.

Speaker: Doctor A. Gasser (Strasbourg, FR)

Access

Abstract

Growth differentiation factor 15 as a predictor of acute kidney injury formation

Speaker: Associate Professor I. Vyshnevska (Kharkiv, UA)

Access

Abstract

Slides

Neladenoson, a partial adenosine A1-receptor agonist, improves mitochondrial function in skeletal muscle of dogs with chronic heart failure

Speaker: Professor H. Sabbah (Detroit, US)

Access

Abstract

Slides

Access the full session

Poster session 3 - Basic science - Translational biomarkers and cardio-renal syndrome

Speakers: Doctor N. Maurea, Assistant Professor M. Trofenciuc, Doctor N. Maurea, Doctor A. Gasser, Associate Professor I. Vyshnevska...

Access

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources